1. Search Result
Search Result
Results for "

Sialyltransferase

" in MedChemExpress (MCE) Product Catalog:

25

Inhibitors & Agonists

8

Biochemical Assay Reagents

2

Natural
Products

8

Recombinant Proteins

Targets Recommended:
Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-E70150

    EC:2.4.3.3; Alpha-N-Acetylgalactosaminide alpha-2,6-Sialyltransferase 1

    Sialyltransferase Cancer
    ST6 Sialyltransferase 1 (EC:2.4.3.3, ST6GALNAC1, SIAT7A, Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 1)? transfers a sialic acid, N-acetylneuraminic acid (NeuAc), in an alpha-2,6 linkage to O-linked GalNAc residues. ST6 Sialyltransferase 1 plays an important role in cancer .
    ST6 Sialyltransferase 1
  • HY-E70065

    Sialyltransferase Infection
    alpha-2,3-Sialyltransferase (PmST2) is a sialyltransferase produced by Pasteurella multocida (Pm) and plays an important role in the pathogenesis of Pm. alpha-2,3-Sialyltransferase (PmST2) can be used to synthesize sialyllactosyl sphingosine (lyso-GM3) .
    alpha-2,3-Sialyltransferase (PmST2)
  • HY-E70062

    Fh8-PmST3

    Endogenous Metabolite Metabolic Disease
    alpha-2,3-Sialyltransferase (PmST3) (EC 2.4.99.4) is a beta-galactoside. alpha-2,3-Sialyltransferase (PmST3) catalyzes the transfer of sialic acid to carbohydrate groups of glycoproteins and glycolipids .
    α-2,3-Sialyltransferase, pasteurella multocida
  • HY-E70298

    ST3GAL1

    Endogenous Metabolite Cancer
    ST3 β-Gal α-2,3-Sialyltransferase 1 (ST3GAL1) is a sialyltransferase whose overexpression in ovarian cancer cell lines enhances cell growth, migration, and invasion capabilities, as well as increases tumorigenicity and resistance to paclitaxel in vivo. ST3 β-Gal α-2,3-Sialyltransferase 1 catalyzes the transfer of sialic acid from cytidine monophosphate-sialic acid to galactose-containing substrates and can be utilized in studies of cancer progression and chemotherapy resistance .
    ST3 β-Gal α-2,3-Sialyltransferase 1
  • HY-E70152

    EC:2.4.3.7; ST6GALNAC4; SIAT3-C

    Biochemical Assay Reagents Cancer
    ST6 Sialyltransferase 4 (EC:2.4.3.7; ST6GALNAC4; SIAT3-C; SIAT3C; SIAT7-D; SIAT7D) catalyzes the transfer of sialic acid from CMP-sialic acid to galactose-containing substrates. ST6 Sialyltransferase 4 promotes hepatocellular carcinogenesis by inducing abnormal glycosylation. .
    ST6 Sialyltransferase 4
  • HY-E70287

    ST6GALNAC5

    Glycosyltransferase Metabolic Disease
    ST6 Sialyltransferase 5 (EC:2.4.3.3, ST6GALNAC5, SIAT7E, ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 5) transfers a sialic acid to N-acetylgalactosamine (GalNAc) residues. ST6 Sialyltransferase 5 is a bio-marker in cervical screening samples .
    ST6 Sialyltransferase 5
  • HY-E70301

    ST8SIA4

    Endogenous Metabolite Cancer
    ST8 alpha-2,8-Sialyltransferase 4 (ST8SIA4) is a sialyltransferase that participates in the sialylation mechanism. ST8 alpha-2,8-Sialyltransferase 4 has also been implicated in breast cancer development and mediates cell proliferation and invasion of cancer cells in a sialyltransferase-dependent manner .
    ST8 alpha-2,8-Sialyltransferase 4
  • HY-E70288

    ST6GALNAC6

    Others Inflammation/Immunology
    ST6 Sialyltransferase 6 (ST6GALNAC6) belongs to the salivary transferase family, which modifies proteins and ceramides on the cell surface, thereby altering intercellular or extracellular matrix interactions. ST6 Sialyltransferase 6 can be used in the study of inflammatory bowel disease (IBD) .
    ST6 Sialyltransferase 6
  • HY-E70063

    Endogenous Metabolite Metabolic Disease
    alpha-2,3-Sialyltransferase (Phα2,3SiaT) is a beta-galactoside. alpha-2,3-Sialyltransferase (Phα2,3SiaT) catalyzes the transfer of sialic acid to carbohydrate groups of glycoproteins and glycolipids .
    alpha-2,3-Sialyltransferase (Phα2,3SiaT)
  • HY-E70300

    Endogenous Metabolite Others
    ST8 alpha-2,8-Sialyltransferase 8B (ST8SIA8 II) is a sialyltransferase that catalyzes the synthesis of α2,8-polysialic acid (polySia) glycans .
    ST8 alpha-2,8-Sialyltransferase 8B
  • HY-E70056

    PmST1(M144D)

    Sialyltransferase Infection
    α2,3-Sialyltransferase, Pasteurella multocida (P-1059) (PmST1(M144D)), a sialyltransferase, can be isolated from Pasteurella multocida. alpha-2,3-Sialyltransferase (PmST1) can be converted into regioselective α2-6-sialyltransferase by saturation mutagenesis and regioselective screening .
    α2,3-Sialyltransferase, Pasteurella multocida (P-1059)
  • HY-E70299

    ST3GAL5

    TGF-beta/Smad Cancer
    ST3 β-Gal α-2,3-Sialyltransferase 5 (ST3GAL5) is a glycosphingolipid (GSL) biosynthetic enzyme that can inhibit TGF-β-induced epithelial-mesenchymal transition (EMT), invasion, and metastasis both in vivo and in vitro. ST3 β-Gal α-2,3-Sialyltransferase 5 can be used in cancer research .
    ST3 β-Gal α-2,3-Sialyltransferase 5
  • HY-E70302

    ST8SIA6

    Endogenous Metabolite Inflammation/Immunology Cancer
    ST8 alpha-2,8-Sialyltransferase 6 (ST8SIA6) is a sialyltransferase that generates α2,8-linked disialic acids, which bind to mouse Siglec-E and human Siglec-7 and -9, and accelerates tumor growth by suppressing anti-tumor immune responses .
    ST8 alpha-2,8-Sialyltransferase 6
  • HY-112535

    Lith-O-Asp analog

    Sialyltransferase Inflammation/Immunology Cancer
    α-2,3-sialyltransferase-IN-1 (Lith-O-Asp analog) is a noncompetitive α-2,3-sialyltransferase inhibitor with an IC50 of 6 μM.
    α-2,3-sialyltransferase-IN-1
  • HY-E70057

    ST8Sia VI; GD3 synthase

    Endogenous Metabolite Metabolic Disease
    alpha-2,8-Sialyltransferase (CstII) (ST8Sia VI) is a member of alpha2,8-sialyltransferase (ST8Sia) family, is often used in biochemical studies. alpha-2,8-Sialyltransferase (CstII) catalyzes elongation of the α2,8-linked oligo/polysialic acid chain on the Sia residue transferred .
    alpha-2,8-Sialyltransferase (CstII)
  • HY-E70055

    Sialyltransferase Others
    alpha-2,6-Sialyltransferase (Pd26ST) (EC 2.4.99.1) is capable of sialylating both terminal and internal galactose and N-acetylgalactosamine, which producing terminal α2,6-sialosides .
    α-2,6-Sialyltransferase, pasteurella multocida (P-1059)
  • HY-E70024

    Sialyltransferase Others
    CMP-sialic acid synthetase (NmCSS) is an essential enzyme involved in the biosynthesis of carbohydrates and glycoconjugates containing sialic acids. CMP-sialic acid synthetase (NmCSS) activates free Sia, converting it to CMP-Sia, which is the only donor substrate for all sialyltransferases .
    CMP-sialic acid synthetase (NmCSS)
  • HY-110288
    3FAx-Neu5Ac
    2 Publications Verification

    Sialyltransferase Metabolic Disease
    3FAx-Neu5Ac (Compound 8), a Sialic acid peracetylated analog, is a sialyltransferase inhibitor. 3FAx-Neu5Ac substantially reduces expression of the sialylated ligand sialyl Lewis X .
    3FAx-Neu5Ac
  • HY-112942

    CMP-Neu5Ac

    Endogenous Metabolite Metabolic Disease
    CMP-Sialic acid (CMP-Neu5Ac) is an allosteric inhibitor of UDP-GlcNAc 2-epimerase. CMP-Sialic acid provides a substrate for Golgi sialyltransferases. CMP-Sialic acid is an important sugar nucleotide for biosynthesis of sialic acid and its conjugates .
    CMP-Sialic acid
  • HY-112942A
    CMP-Sialic acid sodium salt
    2 Publications Verification

    CMP-Neu5Ac sodium salt

    Endogenous Metabolite Metabolic Disease
    CMP-Sialic acid (CMP-Neu5Ac) sodium salt is an allosteric inhibitor of UDP-GlcNAc 2-epimerase. CMP-Sialic acid sodium salt provides a substrate for Golgi sialyltransferases. CMP-Sialic acid sodium salt is an important sugar nucleotide for biosynthesis of sialic acid and its conjugates .
    CMP-Sialic acid sodium salt
  • HY-173496

    Sialyltransferase Integrin VEGFR Akt Cancer
    ST6GAL1-IN-1 is an orally active selective ST6GAL1 inhibitor (IC50 = 20 μM). ST6GAL1-IN-1 exhibits high antimetastatic potential, effectively inhibiting the migration of MDA-MB-231 cells at noncytotoxic concentrations. ST6GAL1-IN-1 can disrupt integrin sialylation in MDA-MB-231 cells. ST6GAL1-IN-1 inhibits tumor angiogenesis and cancer metastasis via the Integrin/VEGFR2-mediated signaling pathway. ST6GAL1-IN-1 effectively suppresses both tumor growth and cancer metastasis on the MDA-MB-231 xenograft model. ST6GAL1-IN-1 can be used for the study of Triple-negative breast cancer (TNBC) .
    ST6GAL1-IN-1
  • HY-E70139

    EC:2.4.1.313; B3GALNT2; β-1,3-N-acetylgalactosaminyltransferase II

    Glucosylceramide Synthase (GCS) Others
    UDP-GalNAc:β-1,3-N-acetylgalactosaminyltransferase 2 ( EC:2.4.1.313; B3GALNT2; β-1,3-N-acetylgalactosaminyltransferase II) is a glycosyltransferase .
    UDP-GalNAc:β-1,3-N-acetylgalactosaminyltransferase 2
  • HY-E70019

    Endogenous Metabolite Metabolic Disease
    alpha-2-3,6-sialidase (BiNanH2) is a sialyltransferase, is often used in biochemical studies. alpha-2-3,6-sialidase (BiNanH2) catalyzes α-2,3/2,6-sialyltransfer from CMP-Neu5Ac to galactoside acceptors .
    alpha-2-3,6-sialidase (BiNanH2)
  • HY-163548

    Sialyltransferase Cancer
    SPP-002 is a sulfate analogue that acts as a potential Sialyltransferase (ST) inhibitor. SPP-002 selectively inhibits n-glycosialylation with inhibition at least an order of magnitude greater than that of unmodified parental cholic acid (LCA). SPP-002 reduces tumor cell migration and invasion by inhibiting the integrin /FAK/Paxillin signaling pathway. SPP-002 can be used in the study of tumor metastasis .
    SPP-002
  • HY-137985

    Stachybotrydial; F 1839M; Stachybotrydial

    HSV Virus Protease Infection
    Mer-NF5003F (Stachybotrydial; F 1839M), a sesquiterpene isolated from Stachybotrys, inhibits avian medulloblastoma virus (AMV) protease (IC50=7.8 μM). Mer-NF5003F inhibits sialyltransferase 6N (ST6N), ST3O, and ST3N (IC50=0.61, 6.7, and 10 μg/mL, respectively), and fucosyltransferase (IC50=11.3 μg/mL). Mer-NF5003F has in vitro activity against herpes simplex virus HSV-1 (IC50=4.32 μg/mL) and multidrug-resistant Plasmodium falciparum K1 strain (IC50=0.85 μg/mL).
    Mer-NF5003F

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

 

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

 

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: